Dal Poggetto John's most recent trade in Sonoma Pharmaceuticals Inc. was a trade of 7,500 Restricted Stock Units done . Disclosure was reported to the exchange on Jan. 2, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Sonoma Pharmaceuticals Inc. | Poggetto John Dal | Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 7,500 | 10,250 | - | - | Restricted Stock Units | |
Sonoma Pharmaceuticals Inc. | Poggetto John Dal | Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 15,000 | 15,000 (0%) | 0% | - | Common Stock, $0.0001 par value | |
Sonoma Pharmaceuticals Inc. | Dal Poggetto John | Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2023 | 50,000 | 55,000 | - | - | Stock option (right to buy) | |
Sonoma Pharmaceuticals Inc. | Poggetto John Dal | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Apr 2020 | 3,086 | 3,201 (0%) | 0% | - | Common Stock, $0.0001 par value |